Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 4069  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 :: Next article
 :: Previous article 
 :: Table of Contents
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (169 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  References

 Article Access Statistics
    PDF Downloaded76    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


Year : 2010  |  Volume : 56  |  Issue : 1  |  Page : 49

Antiphospholipid antibodies in stroke

University College of Medical Sciences (University of Delhi), Delhi, India

Date of Web Publication12-Apr-2010

Correspondence Address:
V Sharma
University College of Medical Sciences (University of Delhi), Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0022-3859.62417

Rights and Permissions

How to cite this article:
Sharma V. Antiphospholipid antibodies in stroke. J Postgrad Med 2010;56:49

How to cite this URL:
Sharma V. Antiphospholipid antibodies in stroke. J Postgrad Med [serial online] 2010 [cited 2023 Mar 22];56:49. Available from:


We read with interest the research article "Antiphospholipid antibodies in young Indian patients with stroke." [1] The authors have done well to evaluate the role of antiphospholipid antibodies (APLA) in young Indian patients with stroke. While the status of diabetes, smoking and hyperlipidemia has been mentioned, the authors have failed to mention the status of hypertension in the study population as also the controls. Hypertension, arguably, is amongst the most important risk factors for ischemic stroke.

It would have been interesting if these patients had been evaluated for other causes of arterial thrombosis e.g. homocystinuria, dysfibrinogenemia and hematological risk factors. This would have clarified the exact causation of APLA in stroke by ruling out other causes of thrombophilia. The results would have been of added value if they had been repeated after 12 weeks. [2] It would have been important for the management of these patients. Such patients who qualify for the diagnosis of antiphospholipid syndrome would need long-term, possibly lifelong anticoagulation. [3]

 :: References Top

1.Mishra MN, Rohatgi S. Antiphospholipid antibodies in young Indian patients with stroke. J Postgrad Med 2009;55:161-4.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006;295:1050-7.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  

This article has been cited by
1 Authorsę reply
Mishra, M. and Rohatgi, S.
Journal of Postgraduate Medicine. 2010; 56(1): 49-50


Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow